![Hiroyuki Hasegawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroyuki Hasegawa
Direttore/Membro del Consiglio presso Kamui Pharma, Inc.
Profilo
Hiroyuki Hasegawa is currently a Director at Kamui Pharma, Inc. and was previously an Executive Officer & GM-Life Science Department at Mitsubishi UFJ Capital Co., Ltd.
He also served as an Outside Director at Veritas In Silico Inc. and Chordia Therapeutics, Inc.
Posizioni attive di Hiroyuki Hasegawa
Società | Posizione | Inizio |
---|---|---|
Mitsubishi UFJ Capital Co., Ltd.
![]() Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Investitore di Private Equity | 01/01/2004 |
Kamui Pharma, Inc.
![]() Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hiroyuki Hasegawa
Società | Posizione | Fine |
---|---|---|
CHORDIA THERAPEUTICS INC. | Direttore/Membro del Consiglio | - |
VERITAS IN SILICO INC. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
VERITAS IN SILICO INC. | Health Technology |
CHORDIA THERAPEUTICS INC. | Health Technology |
Aziende private | 2 |
---|---|
Mitsubishi UFJ Capital Co., Ltd.
![]() Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Finance |
Kamui Pharma, Inc.
![]() Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Hiroyuki Hasegawa